IDH1-mutated AML

Advertisement

cGxPJobs Banner

Five-Year REZLIDHIA Data Reinforces Long-Term AML Outcomes

Dateline IntroductionNovember 18, 2025 — South San Francisco, CA — Rigel Pharmaceuticals has published final five-year clinical data on...

By cGxPwire Editor
November 18, 2025

Read More

Advertisement

cGxPJobs

Directory